Lupin Limited
LUPIN
Rang in aandelen
#2106
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Aandeelprijs
$21.30
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$9.74B
Verandering (1 dag)
-1.83%
Verandering (1 jaar)
-3.70%
Land
IN
Handel Lupin Limited (LUPIN)
Categorie
Healthcare
Operationele marge voor Lupin Limited (LUPIN)
Operationele marge op October 2026 TTM: 25.22%
Volgens de meest recente financiële rapporten en aandelenkoers van Lupin Limited is de huidige operationele marge (TTM) 25.22%. Eind 2024 had het bedrijf een operationele marge van 38.88%.
Geschiedenis van de operationele marge van Lupin Limited van 2004 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 25.22% | -39.59% |
| 2025 | 41.75% | 7.38% |
| 2024 | 38.88% | 671.43% |
| 2023 | 5.04% | -36.04% |
| 2022 | 7.88% | -30.94% |
| 2021 | 11.41% | 26.08% |
| 2020 | 9.05% | -24.46% |
| 2019 | 11.98% | -9.99% |
| 2018 | 13.31% | -41.73% |
| 2017 | 22.84% | -3.26% |
| 2016 | 23.61% | -10.74% |
| 2015 | 26.45% | 3.77% |
| 2014 | 25.49% | 22.08% |
| 2013 | 20.88% | 18.97% |
| 2012 | 17.55% | -2.66% |
| 2011 | 18.03% | -1.53% |
| 2010 | 18.31% | 5.41% |
| 2009 | 17.37% | -18.60% |
| 2008 | 21.34% | -3.35% |
| 2007 | 22.08% | 45.74% |
| 2006 | 15.15% | 55.07% |
| 2005 | 9.77% | -51.27% |
| 2004 | 20.05% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -99.09% |
IN
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.